Appeals & Response Plans
- Nigeria: Yellow Fever Outbreak - Sep 2017
- Nigeria: Floods - Aug 2017
- Nigeria: Hepatitis E Outbreak - Jun 2017
- Nigeria: Cholera Outbreak - Jun 2017
- Nigeria: Meningitis Outbreak - Mar 2017
- West Africa: Armyworm Infestation - Mar 2017
- Nigeria: Lassa Fever Outbreak - Dec 2016
- Nigeria: Measles Outbreak - Oct 2016
- Nigeria: Polio Outbreak - Aug 2016
- Benin/Nigeria/Togo: Lassa Fever Outbreak - Jan 2016
Most read (last 30 days)
Malaria Consortium supports one last season under the ACCESS-SMC project in Nigeria
For the 25 million children who live across the Sahel, where there is a seasonal surge in malaria incidence, the World Health Organization recommends seasonal malaria chemoprevention (SMC) as an effective tool in the fight against malaria. SMC is an antimalarial drug that prevents children under the age of five years old from getting malaria during the four month rainy season. One treatment per month reduces malaria cases by as much as 75 percent.
Abuja, Nigeria 15th June 2016 - “Mortality rates in those states where we ran our severe malaria project fell from 25 to just one percent. These results are, in part, due to the project and show that the use of injectable artesunate for severe malaria works.”
New project prepares to provide seasonal malaria protection in Zamfara and Sokoto
(Nigeria) As World Malaria Day 2015 approaches (25th April), a new project in Nigeria prepares for the distribution of preventive malarial treatments to an estimated 792,132 children under five years old, in 2015 alone, in Zamfara and Sokoto states.
Following a World Health Organisation policy recommendation last year, Malaria Consortium has become the first organisation in Nigeria to fully implement a new approach to prevent malaria illness among children under five known as Seasonal Malaria Chemoprevention (SMC).